Monday, October 13, 2025 4:38:39 PM
KevGee59,
Patients are dying every day because of “the process” established by the status quo which protects those with influence and helps to keep small companies with a real breakthrough from gaining access to decent funding for research and manufacturing development. This happens when small companies won’t fold into those who know their value but refuse to acknowledge it while continuing to rake in huge profits from their own lesser treatments without patients benefiting from the new treatment sooner even though their own research demonstrates a clear benefit from use. Where is the excitement and push to get this to patients ASAP by those with the money, knowledge and ability to value a platform fairly?
Then there is the whole question of why some point to what a jury will do about spoofing and other price fixing practices to those found guilty of the same and the affect of that on patient outcomes. What happens when jurors discover that NWBO represents a pathway to a cancer cure and these companies were working to bankrupt them and then not point at the similarity to those who are killing people outright? I see a pretty clear comparison even though one group is motivated by money and the other by ideology they are both motivated by hate. Best wishes.
Patients are dying every day because of “the process” established by the status quo which protects those with influence and helps to keep small companies with a real breakthrough from gaining access to decent funding for research and manufacturing development. This happens when small companies won’t fold into those who know their value but refuse to acknowledge it while continuing to rake in huge profits from their own lesser treatments without patients benefiting from the new treatment sooner even though their own research demonstrates a clear benefit from use. Where is the excitement and push to get this to patients ASAP by those with the money, knowledge and ability to value a platform fairly?
Then there is the whole question of why some point to what a jury will do about spoofing and other price fixing practices to those found guilty of the same and the affect of that on patient outcomes. What happens when jurors discover that NWBO represents a pathway to a cancer cure and these companies were working to bankrupt them and then not point at the similarity to those who are killing people outright? I see a pretty clear comparison even though one group is motivated by money and the other by ideology they are both motivated by hate. Best wishes.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
